Results 11 to 20 of about 55,899 (275)

Mucosal melanoma [PDF]

open access: yesJournal of Oral Diagnosis, 2020
Primary oral mucosal melanoma (POMM) is a rare neoplasm derived from melanocytes, with unknown aetiology, and different presentation than cutaneous melanoma. It mostly affects the palate and maxillary alveolar ridge, with aspects that may mimic different lesions.
Carla Isabelly Rodrigues-Fernandes   +4 more
openaire   +2 more sources

Anorectal mucosal melanoma. [PDF]

open access: yesSemin Colon Rectal Surg, 2023
Anorectal mucosal melanoma accounts for less than 1 % of all anorectal malignant tumors and a tendency for delayed diagnosis leads to advanced disease at presentation.1,2 Due to the rarity of the disease, there are limited prospective trials exploring the optimal treatment strategies.
Alvarez J, Smith JJ.
europepmc   +3 more sources

Successful Treatment of a Patient with anti-PD1 Antibody-Resistant Advanced Mucosal Melanoma with Nivolumab, Ipilimumab plus Denosumab Combination Therapy

open access: yesCase Reports in Oncology, 2020
Since the incidence of mucosal melanoma is higher in the Japanese population compared to Caucasians, and since mucosal melanoma possesses a lower mutation burden compared to cutaneous melanoma, the efficacy of anti-PD1 antibody (Ab) monotherapy for ...
Taku Fujimura   +7 more
doaj   +1 more source

Advances in the Application of Nanomaterials to the Treatment of Melanoma

open access: yesPharmaceutics, 2022
Melanoma can be divided into cutaneous melanoma, uveal melanoma, mucosal melanoma, etc. It is a very aggressive tumor that is prone to metastasis. Patients with metastatic melanoma have a poor prognosis and shorter survival.
Zeqi Wang   +4 more
doaj   +1 more source

Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006. [PDF]

open access: yes, 2018
BackgroundMucosal melanoma is an aggressive melanoma with poor prognosis. We assessed efficacy of pembrolizumab in patients with advanced mucosal melanoma in KEYNOTE-001 (NCT01295827), -002 (NCT01704287), and -006 (NCT01866319).MethodsPatients received ...
Arance, Ana S   +14 more
core   +1 more source

Candidate therapeutic agents in a newly established triple wild‐type mucosal melanoma cell line

open access: yesCancer Communications, 2022
Background Mucosal melanoma has characteristically distinct genetic features and typically poor prognosis. The lack of representative mucosal melanoma models, especially cell lines, has hindered translational research on this melanoma subtype.
Chaoji Shi   +15 more
doaj   +1 more source

Endoscopic Mucosal Resection of Primary Anorectal Malignant Melanoma:A Case Report [PDF]

open access: yes, 2008
Anorectal melanoma is a rare malignant tumor with a poor prognosis. However, several studies have reported cases of long-term survival. In this report, we present a patient with anorectal melanoma who has survived for 9 years after endoscopic mucosal ...
Fujimoto, Tsuyoshi   +4 more
core   +1 more source

Primary malignant mucosal melanoma of the larynx: A case report and literature review

open access: yesJournal of Pathology of Nepal, 2015
Malignant mucosal melanoma is very rare entity. It comprises about 1% of all malignant melanoma and exhibit more aggressive behaviour than that of skin melanomas.
S Shrestha Khadka, MC Lee, AB Karki
doaj   +1 more source

Frequent genetic aberrations in the cell cycle related genes in mucosal melanoma indicate the potential for targeted therapy

open access: yesJournal of Translational Medicine, 2019
Background Melanoma is one of the most aggressive cancers with extremely poor prognosis, and the median survival time for stage IV patients is approximately 6 to 8 months.
Longwen Xu   +6 more
doaj   +1 more source

Anorectal Melanoma [PDF]

open access: yes, 2018
Anorectal melanoma (AM) is a rare malignancy, characterized by aggressive behavior and a poor prognosis. AM is more frequent in female patients aged over 50 years.
Dario Didona   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy